Point72 Asset Management, L.P. - Oct 17, 2025 SCHEDULE 13G Report for C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CCCC
Shares outstanding
229M shares
Disclosed Ownership
22.6M shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
10/20/2025, 05:58 PM
Date of event
Oct 17, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 9.9% 22.6M 0 22.6M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 9.9% 22.6M 0 22.6M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 9.9% 22.6M 0 22.6M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person